These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 29079874)

  • 1. Study on the effect of EMD386088, a 5-HT
    Jastrzębska-Więsek M; Siwek A; Partyka A; Kołaczkowski M; Walczak M; Smolik M; Latacz G; Kieć-Kononowicz K; Wesołowska A
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Jan; 391(1):37-49. PubMed ID: 29079874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of a mechanism responsible for potential antidepressant activity of EMD 386088, a 5-HT6 partial agonist in rats.
    Jastrzębska-Więsek M; Siwek A; Partyka A; Antkiewicz-Michaluk L; Michaluk J; Romańska I; Kołaczkowski M; Wesołowska A
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):839-49. PubMed ID: 27106213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic antidepressant-like effect of EMD386088, a partial 5-HT
    Jastrzębska-Więsek M; Gdula-Argasińska J; Siwek A; Partyka A; Szewczyk B; Kołaczkowski M; Wesołowska A
    Pharmacol Rep; 2018 Dec; 70(6):1047-1056. PubMed ID: 30292720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant-like activity of EMD 386088, a 5-HT6 receptor partial agonist, following systemic acute and chronic administration to rats.
    Jastrzębska-Więsek M; Siwek A; Partyka A; Szewczyk B; Sowa-Kućma M; Wasik A; Kołaczkowski M; Wesołowska A
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Oct; 388(10):1079-88. PubMed ID: 26077660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial agonist efficacy of EMD386088, a 5-HT6 receptor ligand, in functional in vitro assays.
    Jastrzębska-Więsek M; Siwek A; Kazek G; Nawieśniak B; Partyka A; Marcinkowska M; Kołaczkowski M; Wesołowska A
    Pharmacol Rep; 2013; 65(4):998-1005. PubMed ID: 24145094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel antagonists of 5-HT
    Partyka A; Jastrzębska-Więsek M; Antkiewicz-Michaluk L; Michaluk J; Wąsik A; Canale V; Zajdel P; Kołaczkowski M; Wesołowska A
    Behav Brain Res; 2019 Feb; 359():9-16. PubMed ID: 30312638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of imipramine and amantadine in the forced swimming test in rats. Behavioral and pharmacokinetic studies.
    Rogóz Z; Skuza G; Kuśmider M; Wójcikowski J; Kot M; Daniel WA
    Pol J Pharmacol; 2004; 56(2):179-85. PubMed ID: 15156068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the antidepressant-like effects of carbetocin, an oxytocin agonist, using a modification of the forced swimming test.
    Chaviaras S; Mak P; Ralph D; Krishnan L; Broadbear JH
    Psychopharmacology (Berl); 2010 May; 210(1):35-43. PubMed ID: 20232054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The selective 5-HT(6) receptor antagonist SB-399885 enhances anti-immobility action of antidepressants in rats.
    Wesołowska A; Nikiforuk A
    Eur J Pharmacol; 2008 Mar; 582(1-3):88-93. PubMed ID: 18234190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT6 receptor agonist EMD386088 impairs behavioral flexibility and working memory.
    Amodeo DA; Peterson S; Pahua A; Posadas R; Hernandez A; Hefner E; Qi D; Vega J
    Behav Brain Res; 2018 Sep; 349():8-15. PubMed ID: 29715539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 5-HT3 receptor agonist attenuates the action of antidepressants in the forced swim test in rats.
    Nakagawa Y; Ishima T; Takashima T
    Brain Res; 1998 Mar; 786(1-2):189-93. PubMed ID: 9555008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test.
    Andreasen JT; Nielsen EØ; Christensen JK; Olsen GM; Peters D; Mirza NR; Redrobe JP
    J Psychopharmacol; 2011 Oct; 25(10):1347-56. PubMed ID: 20360159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant-like effects of the acute and chronic administration of nicotine in the rat forced swimming test and its interaction with fluoxetine [correction of flouxetine].
    Vázquez-Palacios G; Bonilla-Jaime H; Velázquez-Moctezuma J
    Pharmacol Biochem Behav; 2004 May; 78(1):165-9. PubMed ID: 15159146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT6 receptor ligands, EMD386088 and SB258585, differentially regulate 5-HT6 receptor-independent events.
    Yun HM; Rhim H
    Toxicol In Vitro; 2011 Dec; 25(8):2035-40. PubMed ID: 21864673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of the anti-immobility action of antidepressants by risperidone in the forced swimming test in mice.
    Rogóż Z; Kabziński M
    Pharmacol Rep; 2011; 63(6):1533-8. PubMed ID: 22358101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine and nicotinic receptor antagonists potentiate the antidepressant-like effects of imipramine and citalopram.
    Popik P; Kozela E; Krawczyk M
    Br J Pharmacol; 2003 Jul; 139(6):1196-202. PubMed ID: 12871839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of zinc with antidepressants in the forced swimming test in mice.
    Szewczyk B; Brański P; Wierońska JM; Pałucha A; Pilc A; Nowak G
    Pol J Pharmacol; 2002; 54(6):681-5. PubMed ID: 12866724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of combined treatment with imipramine and metyrapone in the forced swimming test in rats. Behavioral and pharmacokinetic studies.
    Rogóz Z; Skuza G; Wójcikowski J; Daniel WA
    Pol J Pharmacol; 2003; 55(6):993-9. PubMed ID: 14730094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2007 Aug; 569(1-2):77-83. PubMed ID: 17585901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.
    Wesołowska A; Nikiforuk A
    Neuropharmacology; 2007 Apr; 52(5):1274-83. PubMed ID: 17320917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.